| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |